Modification of the β-adrenoceptor stimulation pathway in zucker obese and obese diabetic rat myocardium

Critical Care Medicine

Volumn 43, Issue 7, 2015, Pages e241-e249

  Jiang, Cheng ^a,b   Carillion, Aude ^a,c   Na, Na ^a,c   De Jong, Audrey ^c,d   Feldman, Sarah ^a   Lacorte, Jean Marc ^c   Bonnefont Rousselot, Dominique ^a,c,e   Riou, Bruno ^a,c   Amour, Julien ^a,c  

^a SORBONNE UNIVERSITÉ   (France)

^b WUHAN UNIVERSITY   (China)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d HÔPITAL SAINT ELOI   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

cardiac muscle; catecholamines; diabetes; heart; obesity; adrenoceptor

Indexed keywords

ADENYLATE CYCLASE; ADIPONECTIN; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BUCLADESINE; C PEPTIDE; CHOLESTEROL; FORSKOLIN; ISOPRENALINE; LEPTIN; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 4; TRIACYLGLYCEROL; RECEPTORS, ADRENERGIC, BETA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DRUG DOSE INCREASE; EXPERIMENTAL STUDY; HEART FUNCTION; HEART LEFT VENTRICLE PAPILLARY MUSCLE; HYPERGLYCEMIA; HYPERLEPTINEMIA; HYPERLIPIDEMIA; IN VITRO STUDY; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ZUCKER FATTY RAT; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; METABOLISM; MYOCARDIUM; OBESITY; PHYSIOLOGY; RATS; RATS, ZUCKER;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; MALE; MYOCARDIUM; OBESITY; RATS; RATS, ZUCKER; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION;

EID: 84937560574     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000999     Document Type: Article

References (37)

1. Gallagher EJ, LeRoith D, Karnieli E. The metabolic syndrome-From insulin resistance to obesity and diabetes. Endocrinol Metab Clin North Am 2008; 37:559-579, vii
2. Glance LG, Wissler R, Mukamel DB, et al. Perioperative outcomes among patients with the modified metabolic syndrome who are undergoing noncardiac surgery. Anesthesiology 2010; 113:859-872
3. Pickkers P, de Keizer N, Dusseljee J, et al. Body mass index is associated with hospital mortality in critically ill patients: An observational cohort study. Crit Care Med 2013; 41:1878-1883
4. Prescott HC, Chang VW, O'Brien JM Jr, et al. Obesity and 1-year outcomes in older Americans with severe sepsis. Crit Care Med 2014; 42:1766-1774
5. Arabi YM, Dara SI, Tamim HM, et al. Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group: Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: An international multicenter cohort study. Crit Care 2013; 17:R72
6. Nelson J, Billeter AT, Seifert B, et al. Obese trauma patients are at increased risk of early hypovolemic shock: A retrospective cohort analysis of 1, 084 severely injured patients. Crit Care 2012; 16:R77
7. Amour J, Kersten JR. Diabetic cardiomyopathy and anesthesia: Bench to bedside. Anesthesiology 2008; 108:524-530
8. Straznicky NE, Grima MT, Sari CI, et al. Neuroadrenergic dysfunction along the diabetes continuum: A comparative study in obese metabolic syndrome subjects. Diabetes 2012; 61:2506-2516
9. Dincer UD. Cardiac β-Adrenoceptor expression is markedly depressed in Ossabaw swine model of cardiometabolic risk. Int J Gen Med 2011; 4:493-499
10. Carroll JF, Jones AE, Hester RL, et al. Reduced cardiac contractile responsiveness to isoproterenol in obese rabbits. Hypertension 1997; 30:1376-1381
11. Carroll JF, Kyser CK, Martin MM: β-Adrenoceptor density and adenylyl cyclase activity in obese rabbit heart. Int J Obesity 2002; 26:627-632
12. Zucker LM, Zucker TF. Fatty a new mutation in the rat. J Heredity 1961; 52:275-278
13. Kanasaki K, Koya D. Biology of obesity: Lessons from animal models of obesity. J Biomed Biotechnol 2011; 2011:197636
14. Friedman JE, de Vente JE, Peterson RG, et al. Altered expression of muscle glucose transporter GLUT-4 in diabetic fatty Zucker rats (ZDF/Drt-fa). Am J Physiol 1991; 261:E782-E788
15. Amour J, Loyer X, Le Guen M, et al. Altered contractile response due to increased beta3-Adrenoceptor stimulation in diabetic cardiomyopathy: The role of nitric oxide synthase 1-derived nitric oxide. Anesthesiology 2007; 107:452-460
16. Birenbaum A, Tesse A, Loyer X, et al. Involvement of beta 3-Adrenoceptor in altered beta-Adrenergic response in senescent heart: Role of nitric oxide synthase 1-derived nitric oxide. Anesthesiology 2008; 109:1045-1053
17. Sassi Y, Abi-Gerges A, Fauconnier J, et al. Regulation of cAMP homeostasis by the efflux protein MRP4 in cardiac myocytes. FASEB J 2012; 26:1009-1017
18. Carillion A, Feldman S, Jiang C, et al. Overexpression of cyclic adenosine monophosphate effluent protein MRP4 induces an altered response to β-Adrenergic stimulation in the senescent rat heart. Anesthesiology 2015; 122:334-342
19. Allain CC, Poon LS, Chan CS, et al. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20:470-475
20. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982; 28:2077-2080
21. Yee HY. Automated hexokinase procedure for assaying glucose in urine, serum, or plasma. Clin Chem 1972; 18:1416-1419
22. Riou B, Lecarpentier Y, Viars P. Inotropic effect of ketamine on rat cardiac papillary muscle. Anesthesiology 1989; 71:116-125
23. Hanouz JL, Riou B, Massias L, et al. Interaction of halothane with alpha-And beta-Adrenoceptor stimulations in rat myocardium. Anesthesiology 1997; 86:147-159
24. David JS, Vivien B, Lecarpentier Y, et al. Extracellular calcium modulates the effects of protamine on rat myocardium. Anesth Analg 2001; 92:817-823
25. Wang B, Chandrasekera PC, Pippin JJ. Leptin-And leptin receptordeficient rodent models: Relevance for human type 2 diabetes. Curr Diabetes Rev 2014; 10:131-145
26. Lima-Leopoldo AP, Leopoldo AS, Sugizaki MM, et al. Myocardial dysfunction and abnormalities in intracellular calcium handling in obese rats. Arq Bras Cardiol 2011; 97:232-240
27. Strassheim D, Houslay MD, Milligan G. Regulation of cardiac adenylate cyclase activity in rodent models of obesity. Biochem J 1992; 283(Part 1):203-208
28. Chatelain P, Robberecht P, De Neef P, et al. Impairment of hormonestimulated cardiac adenylate cyclase activity in the genetically obese (fa/fa) Zucker rat. Pflugers Arch 1981; 390:10-16
29. Khamssi M, Brodde OE. The role of cardiac beta1-And beta2-Adrenoceptor stimulation in heart failure. J Cardiovasc Pharmacol 1990; 16(Suppl 5):S133-S137
30. Gauthier C, Leblais V, Moniotte S, et al. The negative inotropic action of catecholamines: Role of beta3-Adrenoceptors. Can J Physiol Pharmacol 2000; 78:681-690
31. Canale MP, Manca di Villahermosa S, Martino G, et al. Obesityrelated metabolic syndrome: Mechanisms of sympathetic overactivity. Int J Endocrinol 2013; 2013:865965
32. Reynisdottir S, Wahrenberg H, Carlström K, et al. Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-Adrenoceptors. Diabetologia 1994; 37:428-435
33. Amour J, Loyer X, Michelet P, et al. Preservation of the positive lusitropic effect of beta-Adrenoceptors stimulation in diabetic cardiomyopathy. Anesth Analg 2008; 107:1130-1138
34. Coudray N, Beregi JP, Lecarpentier Y, et al. Effects of isoproterenol on myocardial relaxation rate: Influence of the level of load. Am J Physiol 1993; 265:H1645-H1653
35. Abboud I, Lerolle N, Urien S, et al. Pharmacokinetics of epinephrine in patients with septic shock: Modelization and interaction with endogenous neurohormonal status. Crit Care 2009; 13:R120
36. Beloeil H, Mazoit JX, Benhamou D, et al. Norepinephrine kinetics and dynamics in septic shock and trauma patients. Br J Anaesth 2005; 95:782-788
37. Bauman ZM, Killu KF, Rech MA, et al. Racial differences in vasopressor requirements for septic shock. Shock 2014; 41:188-192